This is an interesting case, however its important to point out that the legal debate around this is ongoing. This ruling only applies to the 2nd Circuit at thi

This is an interesting case, however its important to point out that the legal debate around this is ongoing. This ruling only applies to the 2nd Circuit at this point. It's looking like a Supreme Court case will be necessary to ultimately decided this issue, given the murkiness around it. Until then, however, off-label drug marketing is not something companies get away with without a substantial legal battle (often not worth it), and the FDA has so far collected billions of dollars in settlements and fines through successful off-label drug marketing suits.